Top 10 Companies in the Copovidone Market (2026): Market Leaders Powering Global Pharmaceutical Innovation

MARKET INSIGHTS

Global Copovidone market size was valued at USD 120.5 million in 2024. The market is projected to grow from USD 132.8 million in 2025 to USD 218.7 million by 2032, exhibiting a CAGR of 7.4% during the forecast period.

Copovidone is a synthetic polymer composed of vinylpyrrolidone and vinyl acetate monomers, widely used as a pharmaceutical excipient. This water‑soluble polymer exhibits excellent binding, film‑forming, and solubility‑enhancing properties, making it valuable in tablet formulations, coatings, and drug delivery systems. It exists in both powder and liquid forms, with the powder segment currently dominating market share.

The market growth is primarily driven by expanding pharmaceutical manufacturing, particularly in emerging economies, along with increasing demand for novel drug formulations. The polymer’s ability to improve drug bioavailability and stability continues to gain traction. In January 2024, BASF announced capacity expansion for pharmaceutical polymers including Copovidone at their Ludwigshafen site, anticipating 15% demand growth in Europe. Key players like Ashland and JRS Pharma are investing in new production technologies to meet quality standards for regulated markets.

Copovidone Market – View in Detailed Research Report

Top 10 Companies in the Copovidone Market (2026)

1️⃣ Ashland

Headquarters: West Lafayette, Indiana, USA
Key Offering: Pharmaceutical‑grade Copovidone for hot‑melt extrusion, tablet binding, and film coating

Ashland’s Copovidone portfolio is engineered to meet stringent GMP and EXCiPACT certifications, enabling seamless integration into advanced drug delivery systems. The company’s focus on high‑purity grades aligns with global demand for excipients that enhance solubility and stability of active pharmaceutical ingredients.

Sustainability & Growth Initiatives:

• Investment in renewable feedstock sourcing for polymer production
• Expansion of manufacturing capacity in Asia‑Pacific to support regional generic markets
• Continuous R&D to improve film‑forming performance under variable humidity conditions

2️⃣ BASF SE

Headquarters: Ludwigshafen, Germany
Key Offering: Copovidone for hot‑melt extrusion, sustained‑release tablets, and coating films

BASF’s polymer division leverages its global footprint and advanced polymer chemistry to supply excipients that meet USP/NF and Ph. Eur. standards. The company’s recent capacity expansion at Ludwigshafen underscores its commitment to serving the growing European pharmaceutical market.

Sustainability & Growth Initiatives:

• Implementation of circular economy practices in polymer synthesis
• Partnerships with academic institutions to develop next‑generation solubilizers
• Digital tracking of raw‑material provenance to enhance supply‑chain transparency

3️⃣ JH Nanhang Life Sciences Co., Ltd.

Headquarters: Shanghai, China
Key Offering: Pharmaceutical‑grade Copovidone for tablet binding, film coating, and solubilization

JH Nanhang’s production lines are fully GMP‑certified, enabling supply to both domestic and export markets. The company’s focus on high‑purity grades supports the rapid growth of China’s generic drug industry.

Sustainability & Growth Initiatives:

• Investment in low‑energy polymerization processes
• Collaboration with local universities to foster talent in excipient science
• Expansion of regional distribution centers to reduce lead times

4️⃣ Boai NKY Pharmaceuticals Ltd.

Headquarters: Wuhan, China
Key Offering: Copovidone for hot‑melt extrusion, direct compression, and solubilizer applications

Boai NKY has achieved ISO 9001 and ISO 14001 certifications, reinforcing its commitment to quality and environmental stewardship. The company supplies high‑purity grades that meet global regulatory requirements.

Sustainability & Growth Initiatives:

• Adoption of water‑less polymerization methods
• Development of biodegradable excipient blends
• Strategic partnerships with regional contract manufacturers

5️⃣ JRS Pharma

Headquarters: Munich, Germany
Key Offering: Copovidone for film coating, sustained‑release tablets, and solubilization

JRS Pharma’s portfolio is tailored to meet the needs of specialty drug manufacturers. The company’s emphasis on process scalability and regulatory compliance positions it as a preferred supplier for complex drug delivery systems.

Sustainability & Growth Initiatives:

• Integration of green chemistry principles in polymer synthesis
• Expansion of R&D into polymer blends for pediatric formulations
• Digital supply‑chain solutions to track batch consistency

6️⃣ Resonac Corporation

Headquarters: Osaka, Japan
Key Offering: Copovidone for tablet binding, film coating, and solubilizer applications

Resonac’s manufacturing facilities comply with Japan Pharmaceutical Excipients Association standards, ensuring high‑quality excipients for the domestic market and beyond.

Sustainability & Growth Initiatives:

• Implementation of energy‑efficient polymerization reactors
• Development of low‑solvent processes to reduce environmental impact
• Collaboration with global pharma firms to expand market reach

7️⃣ Shanghai Yuking Water Soluble Material Tech Co., Ltd.

Headquarters: Shanghai, China
Key Offering: Copovidone for tablet binding, film coating, and solubilization

Shanghai Yuking’s products are certified under GMP and meet international pharmacopoeial standards, making them suitable for high‑quality generic and specialty drug production.

Sustainability & Growth Initiatives:

• Adoption of renewable raw materials for polymer production
• Expansion of production capacity to meet rising demand in Asia‑Pacific
• Investments in process automation to improve yield and consistency

8️⃣ BOC Sciences

Headquarters: Singapore
Key Offering: Copovidone for tablet binding, film coating, and solubilization

BOC Sciences focuses on delivering excipients that support both generic and specialty pharmaceutical manufacturers in the region. The company’s rigorous quality control processes ensure compliance with global standards.

Sustainability & Growth Initiatives:

• Development of solvent‑free manufacturing routes
• Partnerships with local universities for talent development
• Expansion of regional distribution networks to reduce carbon footprint

9️⃣ Clinivex

Headquarters: Houston, Texas, USA
Key Offering: Copovidone for tablet binding, film coating, and solubilizer applications

Clinivex’s excipients are engineered to enhance drug dissolution and stability, supporting both generic and branded product pipelines. The company’s focus on high‑purity grades aligns with the stringent requirements of the US market.

Sustainability & Growth Initiatives:

• Investment in green polymer synthesis technologies
• Expansion of production capacity to meet North American demand
• Digital traceability of raw materials to ensure quality integrity

🔟 Glentham Life Sciences

Headquarters: Shanghai, China
Key Offering: Copovidone for tablet binding, film coating, and solubilization

Glentham Life Sciences supplies high‑purity excipients that meet global regulatory standards. The company’s focus on process innovation has positioned it as a key supplier for advanced drug delivery systems.

Sustainability & Growth Initiatives:

• Implementation of low‑energy polymerization processes
• Collaboration with international partners to expand market access
• Continuous improvement of quality management systems

Download FREE Sample Report

Get Full Report

Outlook

The Copovidone market is poised to benefit from sustained investment in pharmaceutical manufacturing, especially in emerging economies. The demand for high‑performance excipients that improve solubility and stability of active ingredients is likely to keep pace with the development of next‑generation therapeutics.

Future Trends

• Increased adoption of hot‑melt extrusion and spray‑drying technologies that leverage Copovidone’s low hygroscopicity and excellent plasticity.
• Growth of solvent‑free and sustainable manufacturing processes to reduce environmental impact.
• Expansion of personalized medicine initiatives, driving demand for tailored excipient grades.
• Emerging applications in nutraceuticals and functional supplements, where Copovidone’s film‑forming and taste‑masking properties are leveraged.
• Continued focus on regulatory compliance, with stricter guidelines on elemental impurities and nitrosamine risks.